Karma-Jaya Elliott, MD
THE UNIVERSITY OF UTAH SUGAR HOUSE HEALTH CENTER, 1280 E. STRINGHAM AVENUE · Salt Lake City, UT 84106
Accepts insurance
Listing updated Oct 2, 2026
University of Utah Diabetes & Endocrinology Center — Marie F. Couldwell, MD
Utah Diabetes & Endocrinology Center · 615 Arapeen Drive · Salt Lake City, UT 84108
3.9· 104 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Endocrine / metabolic care
About this practice
The Utah Diabetes & Endocrinology Center at University of Utah Health (615 Arapeen Drive, Salt Lake City) is an academic endocrinology, metabolism, and diabetes clinic. Official materials describe care for diabetes and endocrine/metabolic disease, with faculty clinical interests including pituitary disease, neuroendocrinology, and type 1 diabetes. This is university-hospital endocrinology, not a cash GLP-1 mill; official pages do not list GLP-1 medications as a clinic offering.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | — |
| Cash pay accepted | Yes |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | — |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 3.9
Google rating · 104 reviews
40
reviews in the past year (avg ★ 4.5)
1
reviews mention weight loss
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-18. Read the reviews themselves on the practice's Google listing.
Clinicians
- Marie F. Couldwell, MD
Nearby providers in Salt Lake City
Robert Jones, MD
615 ARAPEEN DR, 100 · Salt Lake City, UT 84108
Accepts insurance
Listing updated Oct 2, 2026
Simply Wellness
3355 South State Street · Salt Lake City, UT 84115
5.0(122 Google reviews · 22 in past year)
Accepts insuranceCash pay3 reviews mention GLP-1
Listing updated Oct 2, 2026
TelehealthAccepts insuranceCash pay
Listing updated Oct 2, 2026
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs